Anindya Roy

Anindya Roy

Co-Founder and CSO at https://www.lila.bio/
Seattle, Washington, United States

Anindya Roy is Co-Founder and Chief Scientific Officer at Lila Biologics. Previously, he was Senior Fellow at the University of Washington. He describes himself as a chemical biologist and protein designer.

Lila Bio wins $3.65M NIH SBIR grant to develop AI-designed long‑acting injectable for pulmonary hypertension

Lila Bio, spun out of David Baker’s UW lab, won a $3.65 million NIH SBIR grant to develop an AI-designed, long-acting injectable protein therapy aimed at modifying disease in pulmonary hypertension. The funding covers two phases—$605,981 for initial animal studies and $3,049,462 for further animal work and patient lung-tissue studies—and builds on Lila’s 2023 $10M seed raise and prior collaboration with Eli Lilly.

Lila Bio wins $3.65M NIH SBIR grant to build AI-designed proteins for pulmonary hypertension

Lila Bio won a $3.65 million NIH SBIR fast-track grant to develop AI-designed therapeutic proteins for pulmonary hypertension, receiving an initial $605,981 phase followed by $3,049,462 in a second phase. The Seattle startup, founded in 2023 by Jake Kraft and Anindya Roy, previously raised a $10 million seed round and will use the non-dilutive funding to advance candidates toward clinical utility.

See all 11 stories, episodes and videos about Anindya Roy.

Organizations

See all 4
  • https://www.lila.bio/ Co-Founder and CSO 2023–present · current
  • Lila Bio logo
    Lila Bio Executive Officer, Director 2023–present, CSO & Co-Founder · current
  • University of Washington logo
    University of Washington Senior Fellow 2014–2023 · past

Education

  • Arizona State University Doctor of Philosophy (PhD), Chemistry and Biochemistry · 2008–2013
  • Indian Institute of Technology, Kharagpur Master of Science (M.Sc.), Chemistry · 2006–2008
  • University of Calcutta Bachelor's degree · 2003–2006

Online